FRIDAY TOUR 2

DIABETES MELLITUS/PREDIABETES
Poster Number Author Name Title
231 Scott Lee PUMP THERAPY SUPERIOR TO FURTHER INTENSIFICATION OF MULTIPLE DAILY INJECTION THERAPY IN TYPE 2 DIABETES
232 Paresh Dandona EFFECT OF LIRAGLUTIDE ON POST PRANDIAL GLUCAGON, CARBOHYDRATE INTAKE AND ON INFLAMMATION IN PATIENTS WITH TYPE 1 DIABETES
233 Brijendra Srivastava PRE-IMPAIRED GLUCOSE TOLERANCE, A RISK FACTOR FOR DIABETES PROGRESSION IN ASIAN INDIANS
234 Lawrence Leiter SIMULTANEOUS REDUCTION IN BOTH A1C AND BODY WEIGHT WITH CANAGLIFLOZIN VERSUS GLIMEPIRIDE IN METFORMIN-TREATED PATIENTS WITH TYPE 2 DIABETES OVER 104 WEEKS
235 Aaron Vinik LONG-TERM SAFETY AND EFFICACY OF REPEATED APPLICATIONS OF CAPSAICIN 8% PATCH (QUTENZATM) IN PAINFUL DIABETIC PERIPHERAL NEUROPATHY: PACE STUDY
236 Subodh Banzal COMPARISON OF INSULIN GLARGINE WITH HUMAN PREMIX INSULIN IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON ORAL HYPOGLYCEMIC DRUGS IN A 24 WEEK RANDOMIZED STUDY
237 Nayananjani Karunasena TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE RISK: AN AGE CUTOFF TO INITIATE STATINS WITHOUT A BASELINE LIPID PROFILE